The herpes simplex keratitis treatment market is expanding due to rising HSV infections, increased healthcare spending, ...
Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for ...
Researchers found that in older adults that were exposed to common infections, they experienced cognitive impairments.
HSV-1, also known as oral herpes or “cold sores,” can spread amongst athletes through skin-to-skin contact and shared ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today announced the closing of its previously announced securities purchase ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it has entered into a securities purchase ...
Early diagnosis of reactive infectious mucocutaneous eruption is important to minimize potential long-term disease ...
Herpafend operates through a multi-layered biological support system that focuses on immune strengthening, viral suppression, ...
Researchers at the University of Kansas have discovered a human gene, the protein PARP14, plays a role in regulating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback